<DOC>
	<DOCNO>NCT00339885</DOCNO>
	<brief_summary>The aim project positionally clone susceptibility gene NIDDM . Patients ascertain Finland previous health survey hospital discharge record . Approximately 400 affect sib pair collect . Families choose , , one parent NIDDM history IDDM . A clinical examination undertaken family member blood drawn DNA isolation . Covariates body weight , blood pressure , lipid level urinary albumin also measure . The unaffected spouse child subset probands invite undergo frequently-sampled intravenous glucose tolerance test ( FSIGT ) measure parameter pancreatic function peripheral insulin resistance ( IR ) . A number unrelated elderly non-diabetic subject also identify conduct population-based association analysis . The FSIGT analysis perform Los Angeles . The DNA ship Bethesda total genomic scan perform use semi-automated fluorescence-based genotyping technology . Data Bethesda , Los Angeles Finland send Ann Arbor parametric non-parametric method use analyse discrete trait NIDDM intermediate trait like IR .</brief_summary>
	<brief_title>Mapping Genes Type 2 ( Non-Insulin Dependent ) Diabetes Mellitus</brief_title>
	<detailed_description>The Finland-United States investigation NIDDM ( FUSION ) study long-term effort identify susceptibility gene Type 2 diabetes ( T2D ) associate quantitative trait . This involve phenotyping DNA analysis thousand individual live Finland , utilize study design originally base affected sib pair . The majority sample already subject genome scan use microsatellite marker original FUSION sample . Additionally , thousand northern European case control subject genome-wide association ( GWA ) analysis and/or fine map part FUSION study . More recently , opportunity provide lowered sequencing cost allow targeted and/or whole genome sequence many individual .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>No eligibility criteria list .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 14, 2016</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>